This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Mass Balance Clinical Trial With TEV-56286

Sponsored by Teva Branded Pharmaceutical Products R&D, Inc.

About this trial

Last updated 8 months ago

Study ID

TV56286-MB-10193

Status

Active, not recruiting

Type

Interventional

Phase

Phase 1

Placebo

No

Accepting

18-75 Years
18 to 65 Years
Male
Male

Trial Timing

Ended 7 months ago

What is this trial about?

Mass balance clinical trial with TEV-56286

What are the participation requirements?

Yes

Inclusion Criteria

- No major trauma or surgery in the 2 months before screening or at any time between screening and the first dose of the study drug, or surgery scheduled during the clinical trial including the follow-up period. - No history of malignancy or treatment of malignancy in the last 5 years. - No personal or family history of arrhythmia, sudden unexplained death at a young age (before 40 years) in a first-degree relative, or long QT syndrome, or a personal history of syncope of undetermined reason or previous treatment for high blood pressure. NOTE- Additional criteria apply, please contact the investigator for more information

No

Exclusion Criteria

- History of relevant drug and/or food allergies. - Exposure to radiation for diagnostic reasons (except dental X-rays and plain X-rays of thorax and bony skeleton [excluding spinal column]), during work, or during participation in a clinical trial in the period of 1 year prior to screening. NOTE- Additional criteria apply, please contact the investigator for more information